ID   IL27A_HUMAN             Reviewed;         243 AA.
AC   Q8NEV9; A0N0L2; Q6P676;
DT   26-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   26-FEB-2008, sequence version 2.
DT   07-APR-2021, entry version 118.
DE   RecName: Full=Interleukin-27 subunit alpha;
DE            Short=IL-27 subunit alpha;
DE            Short=IL-27-A;
DE            Short=IL27-A;
DE   AltName: Full=Interleukin-30;
DE   AltName: Full=p28;
DE   Flags: Precursor;
GN   Name=IL27; Synonyms=IL27A, IL30;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, GLYCOSYLATION, SUBCELLULAR LOCATION,
RP   TISSUE SPECIFICITY, INDUCTION, SUBUNIT, AND VARIANT PRO-119.
RX   PubMed=12121660; DOI=10.1016/s1074-7613(02)00324-2;
RA   Pflanz S., Timans J.C., Cheung J., Rosales R., Kanzler H., Gilbert J.,
RA   Hibbert L., Churakova T., Travis M., Vaisberg E., Blumenschein W.M.,
RA   Mattson J.D., Wagner J.L., To W., Zurawski S., McClanahan T.K.,
RA   Gorman D.M., Bazan J.F., de Waal Malefyt R., Rennick D., Kastelein R.A.;
RT   "IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces
RT   proliferation of naive CD4(+) T cells.";
RL   Immunity 16:779-790(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Livingston R.J., Shaffer T., McFarland I., Nguyen C.P., Stanaway I.B.,
RA   Rajkumar N., Johnson E.J., da Ponte S.H., Willa H., Ahearn M.O.,
RA   Bertucci C., Acklestad J., Carroll A., Swanson J., Gildersleeve H.I.,
RA   Nickerson D.A.;
RL   Submitted (OCT-2006) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-59.
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION.
RX   PubMed=14565860; DOI=10.1089/10799900360708632;
RA   Hibbert L., Pflanz S., De Waal Malefyt R., Kastelein R.A.;
RT   "IL-27 and IFN-alpha signal via Stat1 and Stat3 and induce T-Bet and IL-
RT   12Rbeta2 in naive T cells.";
RL   J. Interferon Cytokine Res. 23:513-522(2003).
RN   [6]
RP   FUNCTION.
RX   PubMed=17068156; DOI=10.1182/blood-2006-02-001578;
RA   Fakruddin J.M., Lempicki R.A., Gorelick R.J., Yang J., Adelsberger J.W.,
RA   Garcia-Pineres A.J., Pinto L.A., Lane H.C., Imamichi T.;
RT   "Noninfectious papilloma virus-like particles inhibit HIV-1 replication:
RT   implications for immune control of HIV-1 infection by IL-27.";
RL   Blood 109:1841-1849(2007).
RN   [7]
RP   FUNCTION.
RX   PubMed=18191724; DOI=10.1016/j.humimm.2007.10.004;
RA   Feng X.M., Chen X.L., Liu N., Chen Z., Zhou Y.L., Han Z.B., Zhang L.,
RA   Han Z.C.;
RT   "Interleukin-27 upregulates major histocompatibility complex class II
RT   expression in primary human endothelial cells through induction of major
RT   histocompatibility complex class II transactivator.";
RL   Hum. Immunol. 68:965-972(2007).
RN   [8]
RP   REVIEW.
RX   PubMed=17294231; DOI=10.1007/s00109-007-0164-7;
RA   Batten M., Ghilardi N.;
RT   "The biology and therapeutic potential of interleukin 27.";
RL   J. Mol. Med. 85:661-672(2007).
RN   [9]
RP   VARIANTS ALA-59 AND PRO-119.
RX   PubMed=17318299; DOI=10.1007/s10038-007-0123-8;
RA   Chae S.-C., Li C.-S., Kim K.M., Yang J.Y., Zhang Q., Lee Y.-C., Yang Y.-S.,
RA   Chung H.-T.;
RT   "Identification of polymorphisms in human interleukin-27 and their
RT   association with asthma in a Korean population.";
RL   J. Hum. Genet. 52:355-361(2007).
CC   -!- FUNCTION: Associates with EBI3 to form the IL-27 interleukin, a
CC       heterodimeric cytokine which functions in innate immunity. IL-27 has
CC       pro- and anti-inflammatory properties, that can regulate T-helper cell
CC       development, suppress T-cell proliferation, stimulate cytotoxic T-cell
CC       activity, induce isotype switching in B-cells, and that has diverse
CC       effects on innate immune cells. Among its target cells are CD4 T-helper
CC       cells which can differentiate in type 1 effector cells (TH1), type 2
CC       effector cells (TH2) and IL17 producing helper T-cells (TH17). It
CC       drives rapid clonal expansion of naive but not memory CD4 T-cells. It
CC       also strongly synergizes with IL-12 to trigger interferon-gamma/IFN-
CC       gamma production of naive CD4 T-cells, binds to the cytokine receptor
CC       WSX-1/TCCR which appears to be required but not sufficient for IL-27-
CC       mediated signal transduction. IL-27 potentiate the early phase of TH1
CC       response and suppress TH2 and TH17 differentiation. It induces the
CC       differentiation of TH1 cells via two distinct pathways, p38
CC       MAPK/TBX21- and ICAM1/ITGAL/ERK-dependent pathways. It also induces
CC       STAT1, STAT3, STAT4 and STAT5 phosphorylation and activates TBX21/T-Bet
CC       via STAT1 with resulting IL12RB2 up-regulation, an event crucial to TH1
CC       cell commitment. It suppresses the expression of GATA3, the inhibitor
CC       TH1 cells development. In CD8 T-cells, it activates STATs as well as
CC       GZMB. IL-27 reveals to be a potent inhibitor of TH17 cell development
CC       and of IL-17 production. Indeed IL27 alone is also able to inhibit the
CC       production of IL17 by CD4 and CD8 T-cells. While IL-27 suppressed the
CC       development of proinflammatory Th17 cells via STAT1, it inhibits the
CC       development of anti-inflammatory inducible regulatory T-cells, iTreg,
CC       independently of STAT1. IL-27 has also an effect on cytokine
CC       production, it suppresses proinflammatory cytokine production such as
CC       IL2, IL4, IL5 and IL6 and activates suppressors of cytokine signaling
CC       such as SOCS1 and SOCS3. Apart from suppression of cytokine production,
CC       IL-27 also antagonizes the effects of some cytokines such as IL6
CC       through direct effects on T-cells. Another important role of IL-27 is
CC       its antitumor activity as well as its antiangiogenic activity with
CC       activation of production of antiangiogenic chemokines such as IP-
CC       10/CXCL10 and MIG/CXCL9. In vein endothelial cells, it induces
CC       IRF1/interferon regulatory factor 1 and increase the expression of MHC
CC       class II transactivator/CIITA with resulting up-regulation of major
CC       histocompatibility complex class II. IL-27 also demonstrates antiviral
CC       activity with inhibitory properties on HIV-1 replication.
CC       {ECO:0000269|PubMed:12121660, ECO:0000269|PubMed:14565860,
CC       ECO:0000269|PubMed:17068156, ECO:0000269|PubMed:18191724}.
CC   -!- SUBUNIT: Heterodimer with EBI3; not disulfide-linked. This heterodimer
CC       is known as interleukin IL-27. {ECO:0000269|PubMed:12121660}.
CC   -!- INTERACTION:
CC       Q8NEV9; O75462: CRLF1; NbExp=2; IntAct=EBI-15887997, EBI-15587902;
CC       Q8NEV9; Q14213: EBI3; NbExp=2; IntAct=EBI-15887997, EBI-742959;
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:12121660}. Note=Does
CC       not seem to be secreted without coexpression of EBI3.
CC   -!- TISSUE SPECIFICITY: Expressed in monocytes and in placenta.
CC       {ECO:0000269|PubMed:12121660}.
CC   -!- INDUCTION: Transiently induced by bacterial lipopolysaccharides (LPS)
CC       stimulation in monocytes. {ECO:0000269|PubMed:12121660}.
CC   -!- PTM: O-glycosylated. {ECO:0000305|PubMed:12121660}.
CC   -!- SIMILARITY: Belongs to the IL-6 superfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Interleukin-27 entry;
CC       URL="https://en.wikipedia.org/wiki/Interleukin_27";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY099296; AAM34498.1; -; mRNA.
DR   EMBL; EF064720; ABK41903.1; -; Genomic_DNA.
DR   EMBL; CH471279; EAW52277.1; -; Genomic_DNA.
DR   EMBL; BC062422; AAH62422.1; -; mRNA.
DR   CCDS; CCDS10633.1; -.
DR   RefSeq; NP_663634.2; NM_145659.3.
DR   BioGRID; 128924; 2.
DR   DIP; DIP-59473N; -.
DR   IntAct; Q8NEV9; 2.
DR   STRING; 9606.ENSP00000349365; -.
DR   iPTMnet; Q8NEV9; -.
DR   PhosphoSitePlus; Q8NEV9; -.
DR   BioMuta; IL27; -.
DR   DMDM; 182701368; -.
DR   jPOST; Q8NEV9; -.
DR   MassIVE; Q8NEV9; -.
DR   PaxDb; Q8NEV9; -.
DR   PeptideAtlas; Q8NEV9; -.
DR   PRIDE; Q8NEV9; -.
DR   ProteomicsDB; 73223; -.
DR   Antibodypedia; 13022; 600 antibodies.
DR   DNASU; 246778; -.
DR   Ensembl; ENST00000356897; ENSP00000349365; ENSG00000197272.
DR   GeneID; 246778; -.
DR   KEGG; hsa:246778; -.
DR   UCSC; uc002dqc.3; human.
DR   CTD; 246778; -.
DR   DisGeNET; 246778; -.
DR   GeneCards; IL27; -.
DR   HGNC; HGNC:19157; IL27.
DR   HPA; ENSG00000197272; Tissue enhanced (blood, brain, liver).
DR   MIM; 608273; gene.
DR   neXtProt; NX_Q8NEV9; -.
DR   OpenTargets; ENSG00000197272; -.
DR   PharmGKB; PA134870478; -.
DR   VEuPathDB; HostDB:ENSG00000197272.2; -.
DR   eggNOG; ENOG502SVMM; Eukaryota.
DR   GeneTree; ENSGT00390000018206; -.
DR   HOGENOM; CLU_102031_0_0_1; -.
DR   InParanoid; Q8NEV9; -.
DR   OMA; PAQVSWP; -.
DR   OrthoDB; 1356544at2759; -.
DR   PhylomeDB; Q8NEV9; -.
DR   TreeFam; TF337498; -.
DR   PathwayCommons; Q8NEV9; -.
DR   Reactome; R-HSA-9020956; Interleukin-27 signaling.
DR   SignaLink; Q8NEV9; -.
DR   SIGNOR; Q8NEV9; -.
DR   BioGRID-ORCS; 246778; 5 hits in 976 CRISPR screens.
DR   ChiTaRS; IL27; human.
DR   GenomeRNAi; 246778; -.
DR   Pharos; Q8NEV9; Tbio.
DR   PRO; PR:Q8NEV9; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; Q8NEV9; protein.
DR   Bgee; ENSG00000197272; Expressed in right lobe of liver and 85 other tissues.
DR   ExpressionAtlas; Q8NEV9; baseline and differential.
DR   Genevisible; Q8NEV9; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; ISS:UniProtKB.
DR   GO; GO:0005125; F:cytokine activity; IEA:UniProtKB-KW.
DR   GO; GO:0045523; F:interleukin-27 receptor binding; ISS:UniProtKB.
DR   GO; GO:0005102; F:signaling receptor binding; ISS:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0070106; P:interleukin-27-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0002230; P:positive regulation of defense response to virus by host; IEA:Ensembl.
DR   GO; GO:0032729; P:positive regulation of interferon-gamma production; IDA:UniProtKB.
DR   GO; GO:0042129; P:regulation of T cell proliferation; ISS:UniProtKB.
DR   GO; GO:0045625; P:regulation of T-helper 1 cell differentiation; IDA:UniProtKB.
DR   GO; GO:0009617; P:response to bacterium; IEA:Ensembl.
DR   InterPro; IPR026207; IL-27_alpha.
DR   PANTHER; PTHR20879; PTHR20879; 1.
PE   1: Evidence at protein level;
KW   Antiviral protein; Cytokine; Glycoprotein; Immunity; Inflammatory response;
KW   Innate immunity; Reference proteome; Secreted; Signal.
FT   SIGNAL          1..28
FT                   /evidence="ECO:0000255"
FT   CHAIN           29..243
FT                   /note="Interleukin-27 subunit alpha"
FT                   /id="PRO_0000320139"
FT   COMPBIAS        164..176
FT                   /note="Glu-rich"
FT   VARIANT         59
FT                   /note="S -> A (in dbSNP:rs17855750)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:17318299"
FT                   /id="VAR_039140"
FT   VARIANT         119
FT                   /note="L -> P (in dbSNP:rs181206)"
FT                   /evidence="ECO:0000269|PubMed:12121660,
FT                   ECO:0000269|PubMed:17318299"
FT                   /id="VAR_039141"
SQ   SEQUENCE   243 AA;  27493 MW;  2FA8B8AB60B606E8 CRC64;
     MGQTAGDLGW RLSLLLLPLL LVQAGVWGFP RPPGRPQLSL QELRREFTVS LHLARKLLSE
     VRGQAHRFAE SHLPGVNLYL LPLGEQLPDV SLTFQAWRRL SDPERLCFIS TTLQPFHALL
     GGLGTQGRWT NMERMQLWAM RLDLRDLQRH LRFQVLAAGF NLPEEEEEEE EEEEEERKGL
     LPGALGSALQ GPAQVSWPQL LSTYRLLHSL ELVLSRAVRE LLLLSKAGHS VWPLGFPTLS
     PQP
//
